{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:24:30Z","timestamp":1778077470096,"version":"3.51.4"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1996,6,1]],"date-time":"1996-06-01T00:00:00Z","timestamp":833587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1996,6,1]],"date-time":"1996-06-01T00:00:00Z","timestamp":833587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1996,6]]},"DOI":"10.1007\/bf00210793","type":"journal-article","created":{"date-parts":[[2004,9,3]],"date-time":"2004-09-03T10:05:26Z","timestamp":1094205926000},"page":"213-217","source":"Crossref","is-referenced-by-count":11,"title":["Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory\/relapsed non-Hodgkin's lymphoma"],"prefix":"10.1007","volume":"14","author":[{"given":"S. L.","family":"Allen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. P.","family":"Schacter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bukowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"O'Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mittelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Rosenbloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Huybensz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00210793_CR1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7164\/antibiotics.39.784","volume":"29","author":"M Konishi","year":"1986","unstructured":"Konishi M, Sugawara K, Kofu F, Nishiyama Y, Tomita K, Miyaki T, Kawaguchi H: Elsamicins, new antitumor antibiotics related to chartreusin. I. Production, isolation, characterization and antitumor activity. J Antibiot (Tokyo) 29:784\u2013791, 1986","journal-title":"J Antibiot (Tokyo)"},{"key":"BF00210793_CR2","volume-title":"Bristol-Myers Squibb Investigator's brochure: Elsamitrucin","author":"LP Schacter","year":"1992","unstructured":"Schacter LP, Yovan N: Bristol-Myers Squibb Investigator's brochure: Elsamitrucin. Bristol-Myers Squibb, Evansville, IN, 1992"},{"key":"BF00210793_CR3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00170854","volume":"7","author":"JE Schurig","year":"1989","unstructured":"Schurig JE, Bradner WT, Basler GA, Rose WC: Experimental antitumor activity of BMY-28090, a new antitumor antibiotic. Invest New Drugs 7:173\u2013178, 1989","journal-title":"Invest New Drugs"},{"key":"BF00210793_CR4","first-page":"71","volume":"9","author":"BC Tanis","year":"1990","unstructured":"Tanis BC, Vermotken JB, ten Bokkel Huinink WW, vd Vijgh WJF, Klein I, McDaniel C, Pinedo HM: Phase I study of elsamicin (BMY-28090). Proc Am Soc Clin Onc 9:71, 1990","journal-title":"Proc Am Soc Clin Onc"},{"key":"BF00210793_CR5","first-page":"1406","volume":"52","author":"MN Raber","year":"1992","unstructured":"Raber MN, Newman RA, Newman BM, Gaver RC, Schacter LP: Phase I trial and clinical pharmacology of elsamitrucin. Cancer Res 52:1406\u20131410, 1992","journal-title":"Cancer Res"},{"key":"BF00210793_CR6","first-page":"72","volume":"9","author":"FP LaCreta","year":"1990","unstructured":"LaCreta FP, Langer C, Walczak J, Tinsley P, Schacter L, Comis RL, Ozols RF, O'Dwyer PJ: Phase I\/pharmacokinetic study of elsamitrucin (BMY-28090, NSC 369327) in patients with advanced cancer. Proc Am Soc Clin Onc 9:72, 1990","journal-title":"Proc Am Soc Clin Onc"},{"issue":"suppl 5","key":"BF00210793_CR7","first-page":"47","volume":"3","author":"J Wanders","year":"1992","unstructured":"Wanders J, Dombemowsky P, Verweij J, Cerny T, Piccart M, ten Bokkel Huinink WW, Calabresi F, Pavlidis N, Franklin H, Winograd B: Phase II studies of elsamitrucin in four different tumor types. Ann Oncol 3(suppl 5):47, 1992","journal-title":"Ann Oncol"},{"key":"BF00210793_CR8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/oxfordjournals.annonc.a058847","volume":"5","author":"J Verweij","year":"1994","unstructured":"Verweij J, Wanders J, Neilsen AL, Pavlidis N, Calabresi F, ten Bokkel Huinink WW, Bruntsch U, Piccart M, Franklin H, Kaye SB: Phase II studies of elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer, and ovarian cancer. Ann Oncol 5:375\u2013376, 1994","journal-title":"Ann Oncol"},{"key":"BF00210793_CR9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00873046","volume":"14","author":"G Goss","year":"1994","unstructured":"Goss G, Letendre F, Stewart D, Shepherd F, Schacter L, Hoogendoorn P, Eisenhauer E: Phase II study of elsamitrucin in non-small cell lung cancer. Invest New Drugs 14:315\u2013317, 1994","journal-title":"Invest New Drugs"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00210793.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00210793\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00210793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00210793.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T03:28:42Z","timestamp":1678505322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00210793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,6]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,6]]}},"alternative-id":["BF00210793"],"URL":"https:\/\/doi.org\/10.1007\/bf00210793","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,6]]}}}